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 In July 1912, the Boston Medical and Surgical Journal celebrated “American 
Supremacy” (1912; see box for historical Journal articles cited), noting that the 
“overwhelming success of the American athletes at the current Olympic games in 
Stockholm is as interesting physiologically as it is nationally gratifying.”  Although 
Sweden won the most medals, athletes from the United States won the gold medal count 
by the thinnest margin, 25 to 24.  What accounted for their dominance?  The large 
population of the United States “is more mixed of all races, and we should therefore be 
able to select the best strains and breed the best mixtures.”  American athletes were 
“better nourished and conditioned” than their competition, “which again should conduce 
to racial physical superiority.”  To top it off, “the intensity of our national disposition 
leads our athletes to train much more eagerly and consistently, and with a keener 
professional intentness for winning.”  Though eugenic undertones have faded, physicians 
have maintained their interest in the Olympics.  The strobe of the quadrennial 
competitions illuminates dramatic changes in medicine and sport. 
 Even before Pierre de Coubertin revived the Olympics in 1896, lore from the 
ancient games circulated in the medical literature.  An 1851 essay about the power of 
mind over body described “the old Greek who died on the spot from excess of joy on 
seeing his three sons crowned with laurel at the Olympic games” (1851).  Oliver Wendell 
Holmes invoked this same episode in his valedictory to Harvard medical graduates 
(1858).  Other authors drew competing lessons from the Olympic legacy.  One warned 
that excessive athletic training diverted energy from mental development, leaving 
adolescents “listless and stupid”: “It was especially remarked by the Greeks that no one 
who in boyhood won the prize at the Olympic games ever distinguished himself 
afterwards” (1867).  An 1891 review, in contrast, hoped that educators would learn from 
the ancient techniques and improve athletic training in U.S. schools (1891). 
 When the modern games began in Athens in 1896, physicians only slowly became 
interested — and mostly in marathons.  Heat and humidity tormented marathoners in St. 
Louis in 1904: only 14 of 27 finished.  The winner, who sustained himself during the race 
with strychnine sulfate, five eggs, and brandy, required the care of four physicians in the 
aftermath.  Heat caused problems again in London and Stockholm.  When the games 
resumed in Antwerp in 1920, athletes were subjected to physical examinations.  The 
United States sent its first team physician — one who had fenced in Stockholm — to the 
Paris games in 1924.  Medical scrutiny has continued ever since.1 
 Physicians have been interested in the Olympics for many reasons.  In the 1920s, 
they probed the limits of human physiology.  One group studied the Yale heavyweight 
rowers who won gold in Paris.  An ingenious contraption revealed that at their racing 
speed — 12 mph — the eight men produced four horsepower, a 20-fold increase over 
resting metabolism (1925).  A 1937 study found that athletes at the 1936 Berlin games 
consumed 7300 calories each day (1937). 
 Sometimes the venue itself became the issue.  The United States threatened to 
boycott the Berlin games until Hitler relented and allowed black and Jewish athletes to 
compete.  Ignoring these tensions, the Journal, which had published a favorable review 
of Nazi health insurance in 1935 (1935), advertised the exhibits and lectures on “Medical 
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Theory and Practice in the New Germany” that had been organized for physicians who 
visited the Olympics (1936).  Boycott politics surfaced again when the Journal’s editor, 
Arnold Relman, visited the Soviet Union in 1980.  Relations had been strained by 
tensions over the Soviet invasion of Afghanistan and the United States’ threat to boycott 
the Moscow games (1980).  Other venues created medical concerns.  Roger Bannister, 
who became a neurologist after breaking the 4-minute mile, “thoroughly disapproved” of 
holding the 1968 games at high altitude in Mexico City (1968).  And indeed several 
hundred athletes collapsed at those Olympics, from migraine, shock, syncope, or 
emotional excitement (1969).  Fears of local pathogens emerged before the Olympics in 
Seoul (Japanese encephalitis) and Barcelona (multidrug-resistant strep) (1988a, 1988b, 
1992a).  Each warning met with vehement rebuttal (1988c, 1992b). Olympic events now 
attract millions of visitors and require careful medical and public health planning.2  Fear 
of terrorism emerged as well, especially after the Atlanta bombing, which left 2 people 
dead and 111 injured (2006). 
 The safety of Olympic sports has remained an enduring concern.  The French 
Academy of Medicine appointed a committee before the 1924 Paris games “to study the 
effects of modern athletics on the human system” (1924).  The resulting tests “revealed 
an alarming number of cases of athletic heart.”  Subsequent studies from the 1920s (on 
athletes from the 1928 Amsterdam games) through the 1990s (on 310 Italian Olympians) 
have produced conflicting evidence on the question of whether intense physical training 
can cause cardiac hypertrophy (1930, 1991a). Some sports received special scrutiny.  On 
the eve of the Atlanta games, a scathing review likened women’s gymnastics to child 
abuse (1996), arguing that although “elite gymnastics can provide a profoundly 
meaningful experience for the athletes,” it could also “result in serious, life-endangering 
physical and psychological disabilities.”  Citing injuries, eating disorders, and social  
problems, the authors warned that “talented youngsters at every competitive level should 
be supported rather than crippled by their sport as they enter adulthood.” 
 A different kind of medical scrutiny emerged in the 1950s.  Commenting on a 
symposium about “Pheidippidian physiology,” a 1957 editorial highlighted the recent 
dramatic improvements in performance at track-and-field events (1957).  What explained 
“these epidemics of broken records”?  The editorial considered possible contributions 
from training, diet, antibiotics, and motivation, but focused on “a speculative 
explanation”: “that amphetamine is being used by some athletes to help them break 
otherwise unassailable records.”  Such practices, if they were in fact occurring, were both 
dangerous and “ethically undesirable.”  Each passing decade brought new scandals about 
performance-enhancing drugs.  After the U.S. Olympic Committee admitted that seven 
cyclists (including four medalists) had received blood transfusions at the Los Angeles 
games, a Sounding Board article condemned this practice (1985).  Not only was this 
practice dangerous, especially in light of the emerging AIDS epidemic; it also “represents 
an attempt to use a medical therapy to provide athletes with an unfair competitive 
advantage.”  When Ben Johnson was stripped of his gold medal at the Seoul Olympics, 
the Journal reviewed the medical risks and legal consequences of anabolic steroids 
(1989).  Erythropoietin came next.  As a Dutch physiologist wrote in the Journal in 1991, 
“the next Olympic Games have already been nicknamed the ‘Hematocrit Olympics’” 
(1991b).  Physicians’ obligation seemed clear: “the medical profession has a 
responsibility to consider carefully these untoward consequences of scientific progress.” 
 Performance-enhancing drugs have cast a long shadow on the modern Olympics.  
Whether the agents are strychnine, heroin, cocaine, or morphine that athletes used in 
Athens in 1896, or the amphetamines, steroids, and erythropoietin that some use today, 
the dilemma remains the same.  As a sports medicine specialist noted in 2004, the 
“attraction of performance-enhancing drugs is simply that they permit the fulfillment of 
the mythical promise of boundless athletic performance — the hubristic ‘faster, higher, 
stronger’ motto of the Olympic Games” (2004).  The ensuing systems of medical 
surveillance have led, inevitably, to “a new type of competition,” in which some athletes 
try to stay one step ahead of the authorities (2001).   
The arms race will continue as medical science produces ever newer means of 
performance enhancement.  Will future athletes try growth factors or gene therapy?3  One 
thing is certain: the Olympics will remain an object of medical fascination. 
 
From the Department of Global Health and Social Medicine, Harvard Medical School, 
Boston; and the Department of the History of Science, Harvard University, Cambridge, 
MA. 
 
Disclosure forms provided by the author are available with the full text of this article at 
NEJM.org. 
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